爱尔眼科涨2.06%，成交额3.18亿元，主力资金净流入1926.35万元

Core Viewpoint - Aier Eye Hospital's stock price has shown fluctuations, with a recent increase of 2.06% but a year-to-date decline of 12.76%, indicating potential volatility in the market [1][2]. Company Overview - Aier Eye Hospital Group Co., Ltd. is located in Changsha, Hunan Province, and was established on January 24, 2003. It was listed on October 30, 2009. The company specializes in providing various ophthalmic medical services, including diagnosis, treatment, and optical services [1]. - The revenue composition of Aier Eye Hospital includes: Refractive projects (40.13%), Vision care services (23.64%), Cataract projects (15.48%), Anterior segment projects (8.96%), Posterior segment projects (6.82%), Other projects (4.67%), and Other (0.30%) [1]. Financial Performance - For the period from January to September 2025, Aier Eye Hospital achieved a revenue of 17.484 billion yuan, representing a year-on-year growth of 7.25%. However, the net profit attributable to shareholders decreased by 9.76% to 3.115 billion yuan [2]. - Since its A-share listing, Aier Eye Hospital has distributed a total of 7.12 billion yuan in dividends, with 3.6 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Aier Eye Hospital had 344,800 shareholders, an increase of 0.27% from the previous period. The average number of circulating shares per person decreased by 0.27% to 23,002 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 163 million shares, and several ETFs, all of which have seen a decrease in their holdings compared to the previous period [3].